Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers.
Simple clinical and laboratory indexes have been identified as predictors of arrhythmic events in implantable cardioverter defibrillator patients. Biomarkers, which are playing a growing role in the prognosis and treatment of patients with heart failure, could provide an auxiliary tool in this context, given that their measurement is now easy and widely available.